Skip to Main Content

Advertisement

Skip Nav Destination

Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients1

Clin Cancer Res (1999) 5 (9): 2526–2531.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal